SGAM
SAGE

Smith Group Asset Management’s Sage Therapeutics SAGE Stock Holding History

Smith Group Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,160
Closed -$808K – 447
2018
Q2 		$808K Buy
5,160
+700
+16% +$110K 0.02% 184
2018
Q1 		$718K Sell
4,460
-2,380
-35% -$404K 0.02% 183
2017
Q4 		$1.13M Hold
6,840
– – 0.04% 164
2017
Q3 		$426K Hold
6,840
– – 0.01% 227
2017
Q2 		$545K Sell
6,840
-100
-1% -$7.23K 0.02% 205
2017
Q1 		$493K Sell
6,940
-10
-0.1% -$586 0.01% 185
2016
Q4 		$355K Buy
+6,950
New +$328K 0.01% 209

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return